South Jersey pharma firm gets FDA approval for generic skin cream
Teligent Inc., a New Jersey-based specialty generic pharmaceutical company, announced Thursday it has received approval for its abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration.
The FDA approved the ANDA for a skin disorder treatment called clobetasol propionate ointment from Teligent, a South Jersey specialty generic pharmaceutical company.
The cream is used to treat a variety of skin disorders including eczema and psoriasis and for contact dermatitis caused by…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: John George Source Type: news
More News: Biotechnology | Clobetasol | Dermatitis | Dermatology | Eczema | Food and Drug Administration (FDA) | Health Management | New Drug Applications | Pharmaceuticals | Psoriasis | Skin